全文获取类型
收费全文 | 8172篇 |
免费 | 583篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 43篇 |
儿科学 | 218篇 |
妇产科学 | 247篇 |
基础医学 | 1344篇 |
口腔科学 | 176篇 |
临床医学 | 885篇 |
内科学 | 1629篇 |
皮肤病学 | 180篇 |
神经病学 | 828篇 |
特种医学 | 290篇 |
外国民族医学 | 7篇 |
外科学 | 723篇 |
综合类 | 42篇 |
一般理论 | 2篇 |
预防医学 | 680篇 |
眼科学 | 86篇 |
药学 | 652篇 |
中国医学 | 19篇 |
肿瘤学 | 756篇 |
出版年
2023年 | 57篇 |
2022年 | 40篇 |
2021年 | 185篇 |
2020年 | 153篇 |
2019年 | 203篇 |
2018年 | 210篇 |
2017年 | 171篇 |
2016年 | 237篇 |
2015年 | 243篇 |
2014年 | 349篇 |
2013年 | 415篇 |
2012年 | 674篇 |
2011年 | 799篇 |
2010年 | 420篇 |
2009年 | 378篇 |
2008年 | 605篇 |
2007年 | 650篇 |
2006年 | 606篇 |
2005年 | 578篇 |
2004年 | 493篇 |
2003年 | 401篇 |
2002年 | 388篇 |
2001年 | 49篇 |
2000年 | 36篇 |
1999年 | 58篇 |
1998年 | 60篇 |
1997年 | 68篇 |
1996年 | 48篇 |
1995年 | 41篇 |
1994年 | 42篇 |
1993年 | 31篇 |
1992年 | 28篇 |
1991年 | 11篇 |
1990年 | 7篇 |
1989年 | 6篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 8篇 |
1985年 | 7篇 |
1984年 | 6篇 |
1983年 | 8篇 |
1982年 | 4篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1979年 | 3篇 |
1977年 | 2篇 |
1973年 | 2篇 |
1970年 | 4篇 |
1968年 | 2篇 |
1914年 | 1篇 |
排序方式: 共有8807条查询结果,搜索用时 31 毫秒
1.
Mahmut Gümüş MD Chieh-I Chen MPH Cristina Ivanescu PhD Saadettin Kilickap MD Igor Bondarenko MD Mustafa Özgüroğlu MD Miranda Gogishvili MD Haci M. Turk MD Irfan Cicin MD James Harnett PharmD Vera Mastey MS Ulrike Naumann MS Matthew Reaney MS Gerasimos Konidaris MS Medha Sasane PhD Keri J. S. Brady PhD Siyu Li PhD Giuseppe Gullo MD Petra Rietschel MD Ahmet Sezer MD 《Cancer》2023,129(1):118-129
2.
Kamolz Lars-Peter Kotzbeck Petra Schintler Michael Spendel Stephan 《European Surgery》2022,54(3):163-169
European Surgery - Large skin defects caused by trauma (e.g., burns) or due to other reasons (e.g., tumor-related skin resections) require sufficient skin replacement. The constant improvement of... 相似文献
3.
4.
Monika Kasper-Sonnenberg Holger M. Koch Petra Apel Maria Rüther Claudia Pälmke Thomas Brüning Marike Kolossa-Gehring 《International journal of hygiene and environmental health》2019,222(8):1084-1092
DINCH (cyclohexane-1,2-dicarboxylic acid-diisononyl ester) is a phthalate plasticizer substitute introduced into the market in 2002. It is increasingly used especially in the production of toys, food contact materials and medical devices. In this measurement campaign on 24-h urine samples of young adults (20–29 years) from the German Environmental Specimen Bank (ESB) collected in 2010, 2011, 2013, 2015 and 2017 (in total 300 samples, 60 samples/year) we analyzed three specific, oxidized DINCH metabolites (OH-MINCH: cyclohexane-1,2-dicarboxylic acid-mono(hydroxy-isononyl) ester; cx-MINCH: cyclohexane-1,2-dicarboxylic acid-mono(carboxy-isooctyl) ester, oxo-MINCH: cyclohexane-1,2-dicarboxylic acid-mono(oxo-isononyl) ester). We merged these data with earlier data of the ESB from the years 1999–2012 and are now able to report levels and time trends of internal DINCH exposure from 1999 to 2017.After first detections of the major oxidized DINCH metabolite OH-MINCH in 2006 (6.7%) detection rates rapidly increased to 43.3% in 2009, 80% in 2010 and 98.3% in 2011 and 2012. From the year 2013 on we could detect OH-MINCH in every urine sample analyzed. The median concentrations of OH-MINCH rapidly increased from 0.15 μg/L in 2010 to twice the concentration in 2011 (0.31 μg/L) with further increases in 2013 (0.37 μg/L), 2015 (0.59 μg/L) and 2017 (0.70 μg/L). Similar increases, albeit at lower detection rates and concentration levels, could be observed for cx-MINCH and oxo-MINCH. All metabolites strongly correlate with each other.For the ESB study population, DINCH exposures are still far below health based guidance values such as the German Human Biomonitoring Value (HBM-I; 4,500 μg/L for the sum of OH-MINCH and cx-MINCH) or the tolerable daily intake (TDI) of EFSA (1 mg/kg bw/d). The median daily DINCH intake (DI) calculated for 2017 was 0.23 μg/kg bw/d, thus 4,310-times lower than the TDI. The maximum DI calculated for one individual in 2012 (42.60 μg/kg bw/d) was a factor of more than 20 below the TDI.The ongoing increase in DINCH exposure needs to be closely monitored in the future, including populations with potentially higher exposures such as children. This close monitoring will enable timely exposure and risk reduction measures if exposures reached critical levels, or if new toxicological data lead to lower health based guidance values. DINCH belongs to the European Human Biomonitoring Initiative (HBM4EU) priority substances for which policy relevant questions still have to be answered. 相似文献
5.
6.
7.
8.
Judith Brock Andreas Schmid Thomas Karrasch Petra Pfefferle Jutta Schlegel Inga Busse Annette Hauenschild Barbara Schmidt Maria Koukou Efthymia Arapogianni Andreas Schultz Miriam Thomalla Secil Akinci Johannes Kruse Winfried Padberg Andreas Schffler Jens Albrecht 《Clinical endocrinology》2019,91(3):400-410
9.
Jaroslav Juracek Michal Stanik Petra Vesela Lenka Radova Jan Dolezel Marek Svoboda Ondrej Slaby 《Urologic oncology》2019,37(3):184.e1-184.e7
10.